株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界における医薬品研究開発受託機関(CRO)市場の規模、シェア、動向分析:タイプ別(創薬、前臨床、臨床)、サービス別、地域別、セグメント予測

Healthcare Contract Research Organization (CRO) Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-Clinical, Clinical), By Service, By Region, And Segment Forecasts, 2019 - 2025

発行 Grand View Research, Inc. 商品コード 639957
出版日 ページ情報 英文 200 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.58円で換算しております。
Back to Top
世界における医薬品研究開発受託機関(CRO)市場の規模、シェア、動向分析:タイプ別(創薬、前臨床、臨床)、サービス別、地域別、セグメント予測 Healthcare Contract Research Organization (CRO) Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-Clinical, Clinical), By Service, By Region, And Segment Forecasts, 2019 - 2025
出版日: 2019年03月06日 ページ情報: 英文 200 Pages
概要

当レポートでは、世界の医薬品研究開発受託機関(CRO)市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法と調査範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場直線見通し
  • 市場セグメンテーションと範囲
  • 浸透度と成長見通しマッピング
  • 治験
  • ユーザー展望分析
  • 法規制枠組み・償還シナリオ
  • 市場動向
    • 市場促進因子分析
    • 市場阻害因子分析
  • 市場分析ツール

第4章 タイプ別市場予測と動向分析

  • 市場シェア分析
  • セグメント概要
  • 市場規模と予測、動向分析
    • 創薬
    • 前臨床
    • 臨床

第5章 サービス別市場予測と動向分析

  • 市場シェア分析
  • セグメント概要
  • 市場規模と予測、動向分析
    • プロジェクトマネジメント/臨床サプライマネジメント
    • データマネジメント
    • 法規制・医務アウトソーシング
    • メディカルライティング
    • 臨床モニタリング
    • 品質マネジメント/保証
    • バイオ統計学
    • 投資家支払い
    • 試験所
    • 患者・サイト募集
    • 技術
    • その他

第6章 地域別予測と動向分析

  • 市場シェア
  • セグメント概要
  • 地域別市場概要
  • 主要企業リスト
  • SWOT分析
  • 市場規模と予測、動向分析
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ

第7章 競合環境

  • 近年の発展と影響分析
  • 戦略枠組み/競合分類
  • ベンダー環境
  • 戦略マッピング
  • 公的企業
  • 民間企業
  • CRO市場シェア
  • モデル定性分析
  • 企業プロファイル
図表

List of Tables

  • TABLE 1 Primary interview details: North America
  • TABLE 2 Primary interview details: Europe
  • TABLE 3 Primary interview details: APAC
  • TABLE 4 Primary interview details: Latin America
  • TABLE 5 Primary interview details: MEA
  • TABLE 6 List of secondary sources
  • TABLE 7 List of abbreviation
  • TABLE 8 Top specialty markets and their approximate spending, 2015
  • TABLE 9 Strategic partnership with pharmaceuticals
  • TABLE 10 Major acquisitions in the CRO market in 2016
  • TABLE 11 Outsourcing trend observed in small-, medium-, and large-scale companies
  • TABLE 12 List of players in North America
  • TABLE 13 List of players in Europe
  • TABLE 14 List of players in Asia Pacific
  • TABLE 15 List of players in Latin America
  • TABLE 16 List of players in MEA
  • TABLE 17 North America healthcare CRO market estimates and forecasts, by country, 2014 - 2025 (USD Million)
  • TABLE 18 North America healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 19 North America drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 20 North America clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 21 North America healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 22 U.S. healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 23 U.S. drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 24 U.S. clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 25 U.S. healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 26 Canada healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 27 Canada drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 28 Canada clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 29 Canada healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 30 Europe healthcare CRO market estimates and forecasts, by country, 2014 - 2025 (USD Million)
  • TABLE 31 Europe healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 32 Europe drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 33 Europe clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 34 Europe healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 35 U.K. healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 36 U.K. drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 37 U.K. clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 38 U.K. healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 39 Germany healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 40 Germany drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 41 Germany clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 42 Germany healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 43 France healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 44 France drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 45 France clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 46 France healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 47 Asia Pacific healthcare CRO market estimates and forecasts, by country, 2014 - 2025 (USD Million)
  • TABLE 48 Asia Pacific healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 49 Asia Pacific drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 50 Asia Pacific clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 51 Asia Pacific healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 52 India healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 53 India drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 54 India clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 55 India healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 56 China healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 57 China drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 58 China clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 59 China healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 60 Japan healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 61 Japan drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 62 Japan clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 63 Japan healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 64 Latin America healthcare CRO market estimates and forecasts, by country, 2014 - 2025 (USD Million)
  • TABLE 65 Latin America healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 66 Latin America drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 67 Latin America clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 68 Latin America healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 69 Brazil healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 70 Brazil drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 71 Brazil clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 72 Brazil healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 73 Mexico healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 74 Mexico drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 75 Mexico clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 76 Mexico healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 77 MEA healthcare CRO market estimates and forecasts, by country, 2014 - 2025 (USD Million)
  • TABLE 78 MEA healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 79 MEA drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 80 MEA clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 81 MEA healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 82 South Africa healthcare CRO market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 83 South Africa drug discovery market estimates and forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 84 South Africa clinical market estimates and forecasts, by trials, 2014 - 2025 (USD Million)
  • TABLE 85 South Africa healthcare CRO market estimates and forecasts, by service, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Primary interviews in North America
  • FIG. 5 Primary interviews in Europe
  • FIG. 6 Primary interviews in Asia Pacific
  • FIG. 7 Primary interviews in Latin America
  • FIG. 8 Primary interviews in MEA
  • FIG. 9 Market research approaches
  • FIG. 10 Value-chain based sizing & forecasting
  • FIG. 11 QFD modeling for market share assessment
  • FIG. 12 Market formulation & validation
  • FIG. 13 Approach 1 analysis
  • FIG. 14 Appraoch 2 analysis
  • FIG. 15 Market summary 2018 (USD Million)
  • FIG. 16 Market segmentation & scope
  • FIG. 17 Penetration & growth prospect mapping
  • FIG. 18 Market trends & outlook
  • FIG. 19 Market driver relevance analysis (Current & future impact)
  • FIG. 20 Benefits of using robotic labs
  • FIG. 21 Areas of scope of improvement for CROs
  • FIG. 22 Pharmaceutical R&D spending 2007-2012 (USD Billion)
  • FIG. 23 Patients in clinical trials, 2015
  • FIG. 24 Market restraint relevance analysis (Current & future impact)
  • FIG. 25 Quality feedback from sponsors, 2011
  • FIG. 26 Porter's Five Forces Analysis
  • FIG. 27 Healthcare CRO market - PESTLE analysis
  • FIG. 28 Healthcare CRO market: Type movement analysis
  • FIG. 29 Healthcare CRO type market: Segment dashboard
  • FIG. 30 Global drug discovery market, 2014 - 2025 (USD Million)
  • FIG. 31 Global target validation market, 2014 - 2025 (USD Million)
  • FIG. 32 Lead identification market, 2014 - 2025 (USD Million)
  • FIG. 33 Lead optimization market, 2014 - 2025 (USD Million)
  • FIG. 34 Global preclinical market, 2014 - 2025 (USD Million)
  • FIG. 35 Global clinical market, 2014 - 2025 (USD Million)
  • FIG. 36 Phase I trial services market, 2014 - 2025 (USD Million)
  • FIG. 37 Phase II trial services market, 2014 - 2025 (USD Million)
  • FIG. 38 Phase III trial services market, 2014 - 2025 (USD Million)
  • FIG. 39 Phase IV trial services market, 2014 - 2025 (USD Million)
  • FIG. 40 Healthcare CRO market: Service movement analysis
  • FIG. 41 Healthcare CRO service market: Segment dashboard
  • FIG. 42 Parameters for measuring success of provider solution
  • FIG. 43 Global project management/clinical supply management market, 2014 - 2025 (USD Million)
  • FIG. 44 Clinical data management flow
  • FIG. 45 Global data management market, 2014 - 2025 (USD Million)
  • FIG. 46 Global regulatory/medical affairs market, 2014 - 2025 (USD Million)
  • FIG. 47 Global medical writing market, 2014 - 2025 (USD Million)
  • FIG. 48 Global clinical monitoring market, 2014 - 2025 (USD Million)
  • FIG. 49 Global quality management/assurance market, 2014 - 2025 (USD Million)
  • FIG. 50 Global biostatistics market, 2014 - 2025 (USD Million)
  • FIG. 51 Global investigator payments market, 2014 - 2025 (USD Million)
  • FIG. 52 Global laboratory market, 2014 - 2025 (USD Million)
  • FIG. 53 Strategic initiatives with positive impact on patient recruitment
  • FIG. 54 Global patient and site recruitment market, 2014 - 2025 (USD Million)
  • FIG. 55 Global technology market, 2014 - 2025 (USD Million)
  • FIG. 56 Global others market, 2014 - 2025 (USD Million)
  • FIG. 57 Healthcare CRO regional market share analysis, 2018 & 2025
  • FIG. 58 Healthcare CRO regional market : Segment dashboard
  • FIG. 59 Regional market place: Key takeaways
  • FIG. 60 North America healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 61 U.S. healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 62 Canada healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 63 Europe healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 64 U.K. healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 65 Germany healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 66 France healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 67 Asia Pacific healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 68 India healthcare CRO Market, 2014 - 2025 (USD Million)
  • FIG. 69 China healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 70 Japan healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 71 Latin America healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 72 Brazil healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 73 Mexico healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 74 MEA healthcare CRO market, 2014 - 2025 (USD Million)
  • FIG. 75 South Africa healthcare CRO Market, 2014 - 2025 (USD Million)
  • FIG. 76 Strategy framework
  • FIG. 77 Strategy framework
  • FIG. 78 Strategy framework
  • FIG. 79 Company market position analysis
  • FIG. 80 Company market position analysis
  • FIG. 81 Healthcare Contract Research Organization (CRO) market share, 2018
目次
Product Code: 978-1-68038-688-2

The global healthcare contract research organization (CRO) market size is expected to reach USD 54.7 billion by 2025, according to a new study by Grand View Research Inc. It is anticipated to expand at a CAGR of 6.6% during the forecast period. Increasing cost of drug development is expected to drive the growth. Drug maker and sponsor companies are under pressure to replace the revenue loss caused by generics, increasing patent expirations, number of partnerships to identify biologics, and growing R&D costs, which has made drug development more expensive and complex.

Regulatory framework for drug discovery and drug development is complex in various countries. Thus, an increasing need for expertise in different areas of drug development is driving the demand for outsourcing services. Drug companies are not only outsourcing production of medicines, but also clinical trials. With increasing privatization of clinical trials, there has been an increase in outsourcing of manufacturing processes to developing regions such as India, China, and Latin American countries.

China and India are projected to witness tremendous growth in near future, owing to their treatment naive patient pool coupled with high disease prevalence. Furthermore, genetically diverse population, highly qualified investigators, and well-equipped hospitals are other factors creating growth opportunities in India for global clinical trials market.

In addition, growing pressure on market players to follow stringent timelines has increased the demand for outsourcing of research activities. Even government organizations are outsourcing their clinical trial activities to CROs so that they can carry out the clinical trials with the required infrastructure, expertise, and minimize cost and timelines. In 2015, the Canadian Federal Budget made an investment of USD 1.33 billion for the Canada Foundation for Innovation (CFI).

In January 2016, Charles River Laboratories International, Inc. entered into a definitive agreement to acquire WIL Research for approximately USD 585 million. The acquisition is expected to strengthen Charles' ability to partner with global clients. The high R&D spending in oncology has also fueled the need for healthcare contract research outsourcing. Realizing this demand, France-based laboratory, XenTech increased its capacity of its animal care to 50% along with increasing collaborative research projects.

CROs are in a process of continuously improving their portfolio by integrating services with technology. This enables them to save more on time and deliver efficient and desired results to the clients. In June 2016, LSK Global Pharma Services Co., Ltd. expanded the use of Medidata Clinical Cloud by Medidata Clinical Solutions, Inc. Established in the year 2000, the company conducts clinical trials at both local and global scale. It utilizes Medidata's electronic data capture, unified randomization, medical coding solution, and trial management supply solution.

In addition to offering improved services, CROs are in the process of collaborating to promote their services at a global level. For instance, In June 2017, PAREXEL entered into a merger agreement with West Street Merger Sub, Inc., a wholly-owned subsidiary of West Street Parent, LLC. According to the merger agreement, PARAXEL will survive as a subsidiary of West Street Parent, LLC, in a transaction valued at approximately USD 5.5 billion.

Further key findings from the study suggest:

  • Clinical trial services led the healthcare Contract Research Organization (CRO) market in 2018 owing to the fact that these services comprise four elaborate phases including human subjects. Increasing complexities in R&D trends have raised the need for expertise, thereby shortening the time required to commercialize the molecule
  • Asia Pacific was the largest regional market with revenue share estimated at over 37% due to the reduced cost it offers compared to U.S and other developed economies. Increasing incidence of chronic and lifestyle diseases such as heart disease and diabetes coupled with ease of patient recruitment and availability of expertise for clinical trials are a few driving factors
  • North America also held a significant market share owing to the presence of global industries, which invest most of their revenue in research activities. In addition, many academic institutes receive grants to undertake these activities. For instance, in July 2015, the University of Toronto received USD 1.5 billion under the Medicine by Design initiative
  • Europe offers tax benefits to large and small-scale companies to promote more contract research outsourcing activities. The large companies can claim 30% deducible from the income of their R&D expenditure
  • Major contributors in the global healthcare CRO market are Quintiles, Covance, Pharmaceutical Product Development, LLC (PPD), Parexel, Charles River Laboratories (CRL), ICON plc, inVentiv Health, and Medidata Solutions. According to the US database of trials, Parexel, Quintiles, and PPD are involved in large number of collaboration with the sponsors pertaining to clinical trials

In September 2017, Laboratory Corporation of America Holdings acquired Chiltern in a transaction worth USD 1.2 billion. Chiltern became a part of LabCorp's Covance Drug Development business unit.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Type
    • 1.1.2 Service
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Latin America
      • 1.3.5.5 Data for primary interviews in MEA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Appraoch 1
    • 1.6.2 Approach 2
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1
    • 1.10.2 Objective - 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Market Snapshot

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ancillary market outlook
  • 3.2 Market Segmentation and Scope
  • 3.3 Penetration & Growth Prospects Mapping
    • 3.3.1 Analysis
  • 3.4 Clinical Trials
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer Behavior Analysis
    • 3.5.2 Market Influencer Analysis
  • 3.6 Regulatory Framework & Reimbursement Scenario
    • 3.6.1 North America
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
    • 3.6.4 Latin America
    • 3.6.5 Middle East
  • 3.7 Market Dynamics
    • 3.7.1 Market Driver Analysis
      • 3.7.1.1 Patent cliff
      • 3.7.1.2 Increasing mergers and collaborations
      • 3.7.1.3 Increasing adoption of advanced technologies
      • 3.7.1.4 Increasing outsourcing of R&D activities
      • 3.7.1.5 Favorable environment for clinical trials in developing countries
    • 3.7.2 Market Restraint Analysis
      • 3.7.2.1 Quality issues of CRO services
      • 3.7.2.2 Intellectual property rights issues
  • 3.8 Business Environment Analysis Tools
    • 3.8.1 Porter's Five Forces Analysis
      • 3.8.1.1 Bargaining power of buyers
      • 3.8.1.2 Bargaining power of suppliers
      • 3.8.1.3 Competitive rivalry
      • 3.8.1.4 Threat of new entrants
      • 3.8.1.5 Threat of substitutes
    • 3.8.2 Healthcare CRO Market - PESTLE Analysis
      • 3.8.2.1 Political & legal landscape
      • 3.8.2.2 Economic landscape
      • 3.8.2.3 Social landscape
      • 3.8.2.4 Technological landscape
      • 3.8.2.5 Environmental landscape

Chapter 4 Healthcare CRO Market: Type Estimates & Trend Analysis

  • 4.1 Healthcare CRO Type Market Share Analysis, 2018 & 2025
  • 4.2 Healthcare CRO Type Market Segment Dashboard
  • 4.3 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the Type Segment
    • 4.3.1 Drug Discovery
      • 4.3.1.1 Drug discovery market, 2014 - 2025 (USD Million)
      • 4.3.1.2 Target validation
      • 4.3.1.2.1 Target validation market, 2014 - 2025 (USD Million)
      • 4.3.1.3 Lead identification
      • 4.3.1.3.1 Lead identification market, 2014 - 2025 (USD Million)
      • 4.3.1.4 Lead optimization
      • 4.3.1.4.1 Lead optimization market, 2014 - 2025 (USD Million)
    • 4.3.2 Preclinical
      • 4.3.2.1 Preclinical market, 2014 - 2025 (USD Million)
    • 4.3.3 Clinical
      • 4.3.3.1 Clinical market, 2014 - 2025 (USD Million)
      • 4.3.3.2 Phase I trial services
      • 4.3.3.2.1 Phase I trial services market, 2014 - 2025 (USD Million)
      • 4.3.3.3 Phase II trial services
      • 4.3.3.3.1 Phase II trial services market, 2014 - 2025 (USD Million)
      • 4.3.3.4 Phase III trial services
      • 4.3.3.4.1 Phase III trial services market, 2014 - 2025 (USD Million)
      • 4.3.3.5 Phase IV trial services
      • 4.3.3.5.1 Phase IV trial services market, 2014 - 2025 (USD Million)

Chapter 5 Healthcare CRO Market: Service Estimates & Trend Analysis

  • 5.1 Healthcare CRO Service Market Share Analysis, 2018 & 2025
  • 5.2 Healthcare CRO Service Market Segment Dashboard
  • 5.3 Competitive Landscape- Qualitative Analysis by Services
  • 5.4 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the Service
    • 5.4.1 Project Management/Clinical Supply Management
      • 5.4.1.1 Project management/clinical supply management market, 2014 - 2025 (USD Million)
    • 5.4.2 Data Management
      • 5.4.2.1 Data management market, 2014 - 2025 (USD Million)
    • 5.4.3 Regulatory/Medical Affairs Outsourcing
      • 5.4.3.1 Regulatory/medical affairs market, 2014 - 2025 (USD Million)
    • 5.4.4 Medical Writing
      • 5.4.4.1 Medical writing market, 2014 - 2025 (USD Million)
    • 5.4.5 Clinical Monitoring
      • 5.4.5.1 Clinical monitoring market, 2014 - 2025 (USD Million)
    • 5.4.6 Quality Management/ Assurance
      • 5.4.6.1 Quality management/assurance market, 2014 - 2025 (USD Million)
    • 5.4.7 Biostatistics
      • 5.4.7.1 Biostatistics market, 2014 - 2025 (USD Million)
    • 5.4.8 Investigator Payments
      • 5.4.8.1 Investigator payments market, 2014 - 2025 (USD Million)
    • 5.4.9 Laboratory
      • 5.4.9.1 Laboratory market, 2014 - 2025 (USD Million)
    • 5.4.10 Patient and Site Recruitment
      • 5.4.10.1 Patient and site recruitment market, 2014 - 2025 (USD Million)
    • 5.4.11 Technology
      • 5.4.11.1 Technology market, 2014 - 2025 (USD Million)
    • 5.4.12 Others
      • 5.4.12.1 Others market, 2014 - 2025 (USD Million)

Chapter 6 Healthcare CRO Market: Regional Estimates & Trend Analysis, by Type and Service

  • 6.1 Healthcare CRO Regional Market Share, 2018 & 2025
  • 6.2 Healthcare CRO Regional Market: Segment Dashboard
  • 6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 6.4 List of Players at Regional Level
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Latin America
    • 6.4.5 MEA
  • 6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.5.1 North America
    • 6.5.2 Europe
    • 6.5.3 Asia Pacific
    • 6.5.4 Latin America
    • 6.5.5 MEA
  • 6.6 Market Size, & Forecasts, and Trend Analysis, 2014 to 2025
    • 6.6.1 North America
      • 6.6.1.1 North America healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.1.2 U.S.
      • 6.6.1.2.1 U.S. healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.1.3 Canada
      • 6.6.1.3.1 Canada healthcare CRO market, 2014 - 2025 (USD Million)
    • 6.6.2 Europe
      • 6.6.2.1 Europe healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.2.2 U.K.
      • 6.6.2.2.1 U.K. healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.2.3 Germany
      • 6.6.2.3.1 Germany healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.2.4 France
      • 6.6.2.4.1 France healthcare CRO market, 2014 - 2025 (USD Million)
    • 6.6.3 Asia Pacific
      • 6.6.3.1 Asia Pacific healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.3.2 India
      • 6.6.3.2.1 India healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.3.3 China
      • 6.6.3.3.1 China healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.3.4 Japan
      • 6.6.3.4.1 Japan healthcare CRO market, 2014 - 2025 (USD Million)
    • 6.6.4 Latin America
      • 6.6.4.1 Latin America healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.4.2 Brazil
      • 6.6.4.2.1 Brazil healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.4.3 Mexico
      • 6.6.4.3.1 Mexico healthcare CRO market, 2014 - 2025 (USD Million)
    • 6.6.5 MEA
      • 6.6.5.1 MEA healthcare CRO market, 2014 - 2025 (USD Million)
      • 6.6.5.2 South Africa
      • 6.6.5.2.1 South Africa healthcare CRO market, 2014 - 2025 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
  • 7.3 Vendor Landscape
    • 7.3.1 List of Key Distributors and Channel Partners
    • 7.3.2 Key Customers
  • 7.4 Strategy Mapping
    • 7.4.1 Launch of New Products
    • 7.4.2 Merger and Acquisition
    • 7.4.3 Geographical Expansion
    • 7.4.4 Partnerships
    • 7.4.5 Marketing & Promotions
  • 7.5 Public Companies
    • 7.5.1 Company Market Position Analysis (Revenue, geographic presence, product portfolio, Strategic Initiatives, Employee Strength)
  • 7.6 Private Companies
    • 7.6.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
  • 7.7 Healthcare Contract Research Organization (CRO) Market Share, 2018
  • 7.8 Healthcare CRO Market: Qualitative Analysis of Models
    • 7.8.1 Transactional Relationships
    • 7.8.2 Functional Service Providers
    • 7.8.3 Alliances
  • 7.9 Company Profiles
    • 7.9.1 IQVIA
      • 7.9.1.1 Company Overview
      • 7.9.1.2 Financial Performance
      • 7.9.1.3 SWOT Analysis
      • 7.9.1.4 Service Benchmarking
      • 7.9.1.5 Strategic Initiatives
    • 7.9.2 Covance Inc.
      • 7.9.2.1 Company Overview
      • 7.9.2.2 Financial Performance
      • 7.9.2.3 SWOT Analysis
      • 7.9.2.4 Service Benchmarking
      • 7.9.2.5 Strategic Initiatives
    • 7.9.3 Pharmaceutical Product Development, LLC (PPD)
      • 7.9.3.1 Company Overview
      • 7.9.3.2 SWOT Analysis
      • 7.9.3.3 Service Benchmarking
      • 7.9.3.4 Strategic Initiatives
    • 7.9.4 PAREXEL
      • 7.9.4.1 Company Overview
      • 7.9.4.2 Financial Performance
      • 7.9.4.3 SWOT Analysis
      • 7.9.4.4 Service Benchmarking
      • 7.9.4.5 Strategic Initiatives
    • 7.9.5 Charles River Laboratories
      • 7.9.5.1 Company Overview
      • 7.9.5.2 Financial Performance
      • 7.9.5.3 SWOT Analysis
      • 7.9.5.4 Service Benchmarking
      • 7.9.5.5 Strategic Initiatives
    • 7.9.6 ICON, plc
      • 7.9.6.1 Company Overview
      • 7.9.6.2 Financial Performance
      • 7.9.6.3 SWOT Analysis
      • 7.9.6.4 Service Benchmarking
      • 7.9.6.5 Strategic Initiatives
    • 7.9.7 Medidata Solutions, Inc.
      • 7.9.7.1 Company Overview
      • 7.9.7.2 Financial Performance
      • 7.9.7.3 SWOT Analysis
      • 7.9.7.4 Service Benchmarking
      • 7.9.7.5 Strategic Initiatives
    • 7.9.8 Syneos Health
      • 7.9.8.1 Company Overview
      • 7.9.8.2 Financial Performance
      • 7.9.8.3 SWOT Analysis
      • 7.9.8.4 Service Benchmarking
      • 7.9.8.5 Strategic Initiatives
    • 7.9.9 Theorem Clinical Research
      • 7.9.9.1 Company Overview
    • 7.9.10 Pharmaron
      • 7.9.10.1 Company Overview
      • 7.9.10.2 SWOT Analysis
      • 7.9.10.3 Service Benchmarking
      • 7.9.10.4 Strategic Initiatives
    • 7.9.11 GVK Biosciences Private Limited
      • 7.9.11.1 Company Overview
      • 7.9.11.2 Financial Performance
      • 7.9.11.3 SWOT Analysis
      • 7.9.11.4 Strategic Initiatives
    • 7.9.12 Dishman Carbogen Amics Limited
      • 7.9.12.1 Company Overview
      • 7.9.12.2 Financial Performance
      • 7.9.12.3 SWOT Analysis
      • 7.9.12.4 Service Benchmarking
      • 7.9.12.5 Strategic Initiatives
Back to Top